Trevi Therapeutics (NASDAQ:TRVI) used its fourth-quarter and year-end 2025 earnings call to outline next steps following what ...

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of ...

Q4 2025 Management View Jennifer Good, CEO, reported that "2025 was a major inflection point for growth at Trevi, driven by our positive data readouts in both the CORAL trial in patients with ...

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough On track ...

Trevi Therapeutics Inc TRVI reported a narrower-than-expected loss for the fourth quarter on Tuesday. The company posted quarterly losses of 6 cents per share which beat the analyst consensus estimate ...

An LPG shortage could push millions of households back to biomass fuels like firewood and coal, increasing exposure to toxic ...

Vaccination rates among young children in Michigan dropped sharply during the first year of the Trump administration, a ...

By Dan Levine, Benjamin Lesser and Kat Stafford PONTIAC, Michigan, March 18 (Reuters) - Vaccination rates among young ...

Resting and staying hydrated helps support recovery from acute bronchitis. Chronic bronchitis requires ongoing medical care for long-term symptoms. Antibiotics can treat bacterial bronchitis, but not ...

Viral disease like chicken pox, herpes, viral fever (allergic), hepatitis A & E are common these days, according to Dr Ajay ...

For the thousands of women who power the famous Abakaliki rice mill in Ebonyi State, the cost of living is paid in coughs, ...